How effective is Methotrexate Lpf for Psoriatic Arthritis? (a real world drug study)
Summary:
Overall ratings: 3.3/5 Long term ratings: 3.4/5
This is a phase IV clinical study of how effective Methotrexate lpf (methotrexate sodium) is for Psoriatic arthritis and for what kind of people. The study is created by eHealthMe from 16 Methotrexate lpf users and is updated continuously.
What is Methotrexate lpf?
Methotrexate lpf has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 636 Methotrexate lpf users. Check the latest studies of Methotrexate lpf.
What is Psoriatic arthritis?
Psoriatic arthritis: no further information found. Check the latest studies of Psoriatic arthritis.
16 people are studied for taking Methotrexate lpf in Psoriatic arthritis
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Methotrexate lpf effectiveness for Psoriatic arthritis (number of people):
Overall:
- not at all: 0
- somewhat: 4
- moderate: 6
- high: 4
- very high: 2
Long Term:
- not at all: 0
- somewhat: 2
- moderate: 4
- high: 4
- very high: 1
Gender of people who take Methotrexate lpf for Psoriatic arthritis *:
- female: 75 %
- male: 25 %
Age of people who take Methotrexate lpf for Psoriatic arthritis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 25.0 %
- 30-39: 0.0 %
- 40-49: 18.75 %
- 50-59: 43.75 %
- 60+: 12.5 %
Who find Methotrexate Lpf more effective for Psoriatic Arthritis?
Gender of people who take Methotrexate lpf for Psoriatic arthritis *:
- female: 83.33 %
- male: 16.67 %
Age of people who take Methotrexate lpf for Psoriatic arthritis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 16.67 %
- 30-39: 0.0 %
- 40-49: 33.33 %
- 50-59: 33.33 %
- 60+: 16.67 %
* Approximation only. Some reports may have incomplete information.
Do you take Methotrexate lpf?
- You can start a phase IV clinical trial to monitor Methotrexate lpf safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Guidelli GM, Tenti S, Fioravanti A, "Severe eosinophilia during anti-tumor necrosis factor-alpha therapy for psoriatic arthritis", Indian Journal of Dermatology, Venereology, and Leprology, 2015 Jan .
- Guidelli GM, Tenti S, Fioravanti A, "Severe eosinophilia during anti-tumor necrosis factor-alpha therapy for psoriatic arthritis", Indian Journal of Dermatology, Venereology, and Leprology, 2015 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Methotrexate lpf (636 reports)
Treatments, associated drugs and conditions:
- Psoriatic arthritis (1,740 reports)
How the study uses the data?
The study is based on methotrexate sodium (the active ingredients of Methotrexate lpf) and Methotrexate lpf (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Avapro and Exjade - 2 seconds ago
- Could Celecoxib cause Meningitis? - 2 seconds ago
- Drug interactions of Ranexa and Zaleplon - 5 seconds ago
- Could Alprazolam cause Gastric Polyps? - 18 seconds ago
- Could Cefazolin cause Post Procedural Infection? - 20 seconds ago
- Drug interactions of Glucovance and Combivent - 33 seconds ago
- Drug interactions of Neurontin and Clindagel - 34 seconds ago
- Could Rosiglitazone Maleate cause Nausea And Vomiting? - 44 seconds ago
- Drug interactions of Dulcolax and Fulvestrant - 45 seconds ago
- Could Eplerenone cause Cardiac Ventricular Thrombosis? - 49 seconds ago